Corrigendum
Corrigendum to
(New and Emerging
Therapies for Osteoporosis
)
E. Michael Lewiecki,
1Manuel Diaz Curiel,
2Joao Lindolfo Borges,
3Annie Kung,
4Maria Luisa Brandi,
5and Hans Peter Dimai
61New Mexico Clinical Research & Osteoporosis Center, 300 Oak St. NE, Albuquerque, NM 87106, USA 2Jimenez Diaz Fundacion, Avenida Reyes Catolicos 2, Madrid 28040, Spain
3Universidade Catolica de Brasilia, DF, Brazil
4University of Hong Kong, 102 Pokfulam Road, Hong Kong
5Maria Luisa Brandi, University of Florence, Viale Pieraccini 6, Florence 50139, Italy 6Medical University Graz, Auenbruggerplatz 15, Graz A-8036, Austria
Correspondence should be addressed to E. Michael Lewiecki; mlewiecki@gmail.com Received 20 April 2017; Accepted 8 May 2017; Published 28 June 2017
Copyright © 2017 E. Michael Lewiecki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the article titled “New and Emerging Therapies for Osteo-porosis” [1], there was an error regarding the FRAX tool, which should be clarified as follows.
The article notes: “The WHO has also developed a fracture risk assessment tool (FRAX) to estimate the 10-year probability of major osteoporotic fracture (clinical spine, hip, proximal humerus, and distal forearm) and hip fracture, using clinical risk factors for fracture and femoral neck bone mineral density (BMD), if available.” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
References
[1] E. M. Lewiecki, M. D. Curiel, J. L. Borges, A. Kung, M. L. Brandi, and H. P. Dimai, “New and emerging therapies for osteop-orosis,” Journal of Osteoporosis, vol. 2010, Article ID 318320, 2 pages, 2010.
[2] N. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX tool for fracture prediction,” Bulletin of the World
Health Organization, vol. 94, p. 862, 2016.
Hindawi
Journal of Osteoporosis
Volume 2017, Article ID 4175180, 1 page https://doi.org/10.1155/2017/4175180
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATIONof
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural
Neurology
Endocrinology
International Journal of Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed
Research International
Oncology
Journal ofHindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal ofHindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Computational and Mathematical Methods in Medicine
Ophthalmology
Journal ofHindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal ofHindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014